Literature DB >> 19923452

Cutting edge: inhibitory effects of CD4 and CD8 on T cell activation induced by high-affinity noncognate ligands.

Adam S Chervin1, Jennifer D Stone, Natalie A Bowerman, David M Kranz.   

Abstract

It has been proposed that MHC restriction during thymocyte selection is controlled by coreceptor (CD4 or CD8) sequestration of the signaling molecule Lck. We explored this model as a mechanism for preventing peripheral T cell activation due to non-MHC ligand cross-reactivities of TCRs. TCRs that have a range of affinities for a class I MHC ligand were transduced into a T cell hybridoma in the absence or presence of coreceptors. High and intermediate affinity TCRs (K(D) = 17 and 540 nM) did not require CD8 for T cell activity, but CD4 acted as a potent inhibitor of the intermediate affinity TCR. These and other findings support the view that even high-affinity TCR:ligand interactions can be influenced by coreceptor sequestration of Lck. Thus, CD4 and CD8 act as "coreceptor inhibitors" to maintain appropriate TCR-mediated MHC restriction in peripheral T cell activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923452     DOI: 10.4049/jimmunol.0901664

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains.

Authors:  D H Aggen; A S Chervin; T M Schmitt; B Engels; J D Stone; S A Richman; K H Piepenbrink; B M Baker; P D Greenberg; H Schreiber; D M Kranz
Journal:  Gene Ther       Date:  2011-07-14       Impact factor: 5.250

2.  Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8.

Authors:  Jennifer D Stone; David H Aggen; Adam S Chervin; Samanthi Narayanan; Thomas M Schmitt; Philip D Greenberg; David M Kranz
Journal:  J Immunol       Date:  2011-03-30       Impact factor: 5.422

3.  Interferon γ limits the effectiveness of melanoma peptide vaccines.

Authors:  Hyun-Il Cho; Young-Ran Lee; Esteban Celis
Journal:  Blood       Date:  2010-10-01       Impact factor: 22.113

Review 4.  TCR affinity for p/MHC formed by tumor antigens that are self-proteins: impact on efficacy and toxicity.

Authors:  Jennifer D Stone; Daniel T Harris; David M Kranz
Journal:  Curr Opin Immunol       Date:  2015-01-22       Impact factor: 7.486

5.  A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control.

Authors:  Jennifer D Stone; Daniel T Harris; Carolina M Soto; Adam S Chervin; David H Aggen; Edward J Roy; David M Kranz
Journal:  Cancer Immunol Immunother       Date:  2014-08-01       Impact factor: 6.968

Review 6.  Phenotypic models of T cell activation.

Authors:  Melissa Lever; Philip K Maini; P Anton van der Merwe; Omer Dushek
Journal:  Nat Rev Immunol       Date:  2014-09       Impact factor: 53.106

7.  CD4 Inhibits Helper T Cell Activation at Lower Affinity Threshold for Full-Length T Cell Receptors Than Single Chain Signaling Constructs.

Authors:  Deborah K Johnson; Wyatt Magoffin; Sheldon J Myers; Jordan G Finnell; John C Hancock; Taylor S Orton; Stephen P Persaud; Kenneth A Christensen; K Scott Weber
Journal:  Front Immunol       Date:  2021-01-19       Impact factor: 7.561

8.  Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapies.

Authors:  Jennifer D Stone; David M Kranz
Journal:  Front Immunol       Date:  2013-08-21       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.